Hemlibra safely reduces bleeding episodes in people with hemophilia A without inhibitors, per a review study that confirmed ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later — 13-year follow-up shows stable factor IX expression and low bleeding rates ...

Certain immune markers in the blood may help predict ITI response among hemophilia A patients given immune tolerance induction, a study found.

On June 26, Pfizer announced positive topline results from its Phase 3 BASIS study evaluating HYMPAVZI (marstacimab) for individuals aged 12 to <75 years living with hemophilia A or B with inhibitors.

Pfizer PFE announced that the phase III BASIS study evaluating its anti-TFPI inhibitor Hympavzi (marstacimab) for treating patients with hemophilia A or B with inhibitors met its primary endpoint as ...

(RTTNews) - Pfizer Inc. (PFE) Thursday reported positive topline results from the Phase 3 BASIS study of Hympavzi for adults and adolescents living with hemophilia A or B with inhibitors. The ...

Pfizer said a late-stage study of its Hympavzi hemophilia drug met its key goals in patients with the blood-clotting disorder who have inhibitors that can render some treatments ineffective.

Topline data were announced from a phase 3 trial evaluating marstacimab for adults and adolescents living with hemophilia A or B with inhibitors.

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study ( NCT03938792 ) evaluating HYMPAVZI™ (marstacimab) for adults and adolescents living with hemophilia ...

Novo Nordisk A/S recently presented data regarding their antibody fragment Inno-8 for the potential treatment of hemophilia A. Inno-8 was characterized in vitro alone or in combination with hemostatic ...

Total knee replacement is frequently needed by hemophilia patients and greatly improves their quality of life, but it carries a higher risk of bleeding and infection for hemophiliacs than it does ...